Study of Sleep Disorders in Prodromal and Definite Parkinsons Disease
SOMPARK
Controlled, Multicenter Study of Sleep Disorders in Prodromal and Definite Parkinsons Disease
1 other identifier
interventional
457
1 country
6
Brief Summary
Multicenter controlled study of sleep disorders in isolated REM Behavior Disorder and Parkinson\'s disease (SOMPARK)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable parkinson-disease
Started Mar 2025
Typical duration for not_applicable parkinson-disease
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 30, 2024
CompletedFirst Posted
Study publicly available on registry
September 3, 2024
CompletedStudy Start
First participant enrolled
March 18, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 1, 2028
March 6, 2026
March 1, 2026
3 years
August 30, 2024
March 4, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Polysomnography to compare sleep efficiency
Using polysomnography to compare sleep efficiency in the 3 study populations during the first night
25 months
Study Arms (1)
Participants
EXPERIMENTALStudy of the sleep with polysomnography during a 2-days stay in hospital. Other exam will be done during the 2 days.
Interventions
An overnight sleep study
Eligibility Criteria
You may qualify if:
- Common to all groups:
- Age superior 18 years
- Patients who have received complete information about the study from an investigator and who fully consent to participate.
- For Parkinson Disease (PD):
- Patients followed for PD diagnosed according to international criteria for the diagnosis of PD (MDS criteria),
- A MoCA score greater than 20/30
- No treatment with deep brain stimulation.
- For REM Sleep Behavior Disorder (RBD):
- Diagnosis of RBD according to ICSD-3 criteria: presence on polysomnography of an abnormal elevation of muscle tone during REM sleep (more than 18% of REM sleep without chin atonia) and/or the presence of REM sleep behaviors on video-polysomnography,
- Absence of progressive neurodegenerative pathology: absence of diagnostic criteria for PD, multiple system atrophy, or Lewy body dementia.
- For healthy controls:
- \- No neurological or psychiatric disease
You may not qualify if:
- Common to all groups:
- Pregnant or breastfeeding women
- Subjects under guardianship/conservatorship
- Persons deprived of liberty.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (6)
CHU de Clermont-Ferrand
Clermont-Ferrand, 63000, France
CHU de Lille
Lille, 59037, France
CHU de Lyon
Lyon, 69004, France
CHU de Nantes
Nantes, 44093, France
CHU de Nîmes
Nîmes, 30000, France
CHU Pitié Salpêtrière
Paris, 75013, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 30, 2024
First Posted
September 3, 2024
Study Start
March 18, 2025
Primary Completion (Estimated)
April 1, 2028
Study Completion (Estimated)
April 1, 2028
Last Updated
March 6, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share